{"podcast":{"title":"Let's Talk Risk! Podcast","slug":"let-s-talk-risk-podcast-6693844","podcast_index_feed_id":6693844,"rss_url":"https://api.substack.com/feed/podcast/1477050.rss","website_url":"https://naveenagarwalphd.substack.com/podcast","image_url":"https://substackcdn.com/feed/podcast/1477050/ee2039dcd34796f25b1263b7e1659bef.jpg","author":"Where MedTech professionals gain clarity and confidence to navigate complex decisions.","episode_count":166,"summary":"Where MedTech professionals gain clarity and confidence to navigate complex risk, quality, and leadership challenges.","last_synced_at":null,"page_url":"https://stenobird.com/podcast/let-s-talk-risk-podcast-6693844"},"episode":{"title":"LTR 146: Ganesh Sabat on Scaling MedTech Through Quality","slug":"ltr-146-ganesh-sabat-on-scaling-medtech-through-quality","published_at":"2026-03-06T13:00:00+00:00","page_url":"https://stenobird.com/podcast/let-s-talk-risk-podcast-6693844/ltr-146-ganesh-sabat-on-scaling-medtech-through-quality","show_page_url":"https://stenobird.com/podcast/let-s-talk-risk-podcast-6693844","url":"https://naveenagarwalphd.substack.com/p/ltr-146-ganesh-sabat-on-scaling-medtech-through-quality","audio_url":"https://api.substack.com/feed/podcast/188915116/0fb9590a5e625afde2889e242f3d7567.mp3","summary":"Summary “A company can become world class the day the quality team decides.” In this Let’s Talk Risk! conversation , host Naveen Agarwal engages with Ganesh Sabat, former former CEO of Sahajanand Medical Technologies (SMT) and now Founder & Managing Partner of MedArtha Capital about a simple but hard truth: global scale in MedTech is earned through quality execution, not marketing narratives. Ganesh walks through SMT’s transformation from an innovative startup into a globally recognized cardiovascular device company, then zooms out to India’s broader MedTech ambition. We unpack what’s missing (talent depth, shared learning, true design ownership), what’s emerging (incubation + device parks + incentives), and why quality leaders are the real “make-or-break” force behind India’s credibility on the world stage. Listen to the full 30-minute podcast or jump to a section of interest listed below. Chapters 00:00 Welcome and Introduction 02:09 SMT story: from “innovative startup” to global scale 04:54 The turning point: why Ganesh bet on quality as the growth lever 06:13 What investors demanded: proof, discipline, and scalable systems 08:39 India ecosystem reality: pharma-quality mindset vs device-grade rigor 11:22 “Quality as a system”: building defect prevention into process + design 15:21 Building the ecosystem: why shared learning + capability depth matter 18:58 Challenges and opportunities for MedTech startup 21:02 Achieving global success not through low-cost but high quality 24:25 Closing remarks If you enjoyed this podcast, consider subscribing to the Let’s Talk Risk! newsletter . Suggested links: LTR: What QA/RA Professionals Need to Know About MedTech in India . LTR: Navigating the Regulatory Landscape for SaMD in India . LTR: Atty Chakraborty on India’s Rising MedTe…","meta_description":"Summary “A company can become world class the day the quality team decides.” In this Let’s Talk Risk! conversation , host Naveen Agarwal engages with Gane…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1535,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/let-s-talk-risk-podcast-6693844/episodes/ltr-146-ganesh-sabat-on-scaling-medtech-through-quality/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/let-s-talk-risk-podcast-6693844/ltr-146-ganesh-sabat-on-scaling-medtech-through-quality.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}